Cure JM Leader Publishes New JDM Research

Tracy Van Ness

Cure JM is proud to share exciting news from our community. Dr. Tracy Van Ness, DHSc, PA‑C, has published a new peer‑reviewed article, Juvenile Dermatomyositis: Multisystem Impacts and Evolving Treatment Paradigms, contributing important insights to the scientific understanding of JDM. 

Access the article

Dr. Van Ness is a standout leader in the JM community — serving as a Director on the Cure JM Board of Directors, a member of the Research Committee, Co‑Chair of Walk Strong New York, and a dedicated JM mom. Her work bridges clinical expertise, research leadership, and lived experience, making her voice especially meaningful in advancing care for children, teens, and young adults with JM.

This publication highlights Dr. Van Ness’s commitment to improving outcomes for JM families and strengthening the research foundation that drives better treatments and long‑term health.

Cure JM celebrates this achievement and is grateful for the many ways Dr. Van Ness helps move our mission forward.

Vamorolone FAQ

Vamorolone FAQs in JM

With the looming FDA approval of the drug vamorolone in Duchenne muscular dystrophy, there are questions surrounding the drug’s status for trials in juvenile myositis. We have consulted with JM experts on the potential implications of a pending approval for the drug in another disease and what this currently means for JM patients living in the U.S.

Cure JM Video Resources

Video Resources

At Cure JM, we want all our information to be accessible to you and your family. We have compiled all of our video resources in one place for you to view at your leisure.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.